Industries - Biotech
Finance built for Biotech companies
Biotech founders are focused on advancing life-changing science, but the financial complexity of running an R&D-stage company demands specialized support. Finvisor organizes finances, maximizes R&D tax credits, and keeps you investor-ready in this highly regulated industry.
600+
Companies supported
$500M+
Raised by clients
12+
Years in practice
Why founders move their books to Finvisor
How We Support Biotech Companies
Biotech companies operate under financial conditions unlike most startups, requiring purpose-built systems to support long development timelines, capital-intensive research, and rigorous compliance. Finvisor builds the financial foundation biotech companies need to stay compliant, maximize R&D tax credits, maintain investor readiness, and track runway throughout the development lifecycle.
Grant Accounting and Compliance
Many early-stage biotech companies rely on SBIR, NIH and other government grants to fund R&D. The accounting requirements that come with those awards are detailed and unforgiving.
Keep Grant Records Audit-Ready
We build accounting systems that align bookkeeping with grant budgets and simplify reconciliation and reporting. Receipts, invoices, and time records stay organized and audit-ready.
R&D Expense Tracking and Tax Credit Optimization
Biotech companies must accurately classify R&D expenses to support financial reporting and maximize tax credits. Misclassified costs reduce available credits and create unnecessary complexity at tax time.
Capture Every Eligible R&D Tax Credit
We implement biotech-specific accounting systems that track expenses by category, document qualifying costs year-round, and help founders maximize R&D tax credits while extending runway.
Cash Management and Investor Reporting
Long development cycles and delayed revenue make burn rate visibility and runway forecasting essential. Investors expect clean financials and milestone-based projections that can withstand due diligence.
Keep Runway and Reporting on Track
We implement bookkeeping and reporting processes aligned with biotech standards, maintain audit-ready records, and build runway forecasts tied to development milestones.
Grant Accounting and Compliance
Many early-stage biotech companies rely on SBIR, NIH and other government grants to fund R&D. The accounting requirements that come with those awards are detailed and unforgiving.
Keep Grant Records Audit-Ready
We build accounting systems that align bookkeeping with grant budgets and simplify reconciliation and reporting. Receipts, invoices, and time records stay organized and audit-ready.
R&D Expense Tracking and Tax Credit Optimization
Biotech companies must accurately classify R&D expenses to support financial reporting and maximize tax credits. Misclassified costs reduce available credits and create unnecessary complexity at tax time.
Capture Every Eligible R&D Tax Credit
We implement biotech-specific accounting systems that track expenses by category, document qualifying costs year-round, and help founders maximize R&D tax credits while extending runway.
Cash Management and Investor Reporting
Long development cycles and delayed revenue make burn rate visibility and runway forecasting essential. Investors expect clean financials and milestone-based projections that can withstand due diligence.
Keep Runway and Reporting on Track
We implement bookkeeping and reporting processes aligned with biotech standards, maintain audit-ready records, and build runway forecasts tied to development milestones.
Services
A complete finance team that grows with you.
Financial experts who know your business, and care about where you’re going.
Accurate books, closed in 5 days.
What your team handles:
- Clean books, closed within 5 business days
- Dedicated accounting and controller support
- Financials ready for investors, audits, and diligence
- AI-enhanced workflows that improve speed and reduce errors
- A back-office team built to scale alongside your business
The real people behind the services
What founders say
The finance partner founders wish they had sooner.
“I have observed that Jodi is proactive, exceptionally intelligent, and extremely capable. She has proven to be a valuable asset to our cash flow, which is vital for a small business like XiO.”
Bryan Collins, COO
XiO, Inc
“The Finvisor team has been great. Our financials had been a mess since we opened and the Finvisor team cleaned them up and have been on top of every detail.”
Ryan Schaper, Operations Manager
Flagship
“Unlike other firms that we have worked with in the past, they are exceptional listeners, provide sound and scalable advice, and always have our best interests at heart.”
Brian Hassan, Co-Founder
Kickfin
FAQ
Questions we hear all the time.
If yours isn't here, we'd love to answer it directly.
Biotech companies face longer pre-revenue periods, complex R&D accounting, specialized tax incentives, and investor reporting that extends beyond financials to scientific and operational milestones. Generic accounting cannot manage this complexity, and early mistakes can become costly.
Turn breakthrough science into sustainable growth.
Talk to an advisor and see how Finvisor can support your organization.